Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Medhavi Honhar

Concepts (31)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation
4
2020
556
0.350
Why?
Transplantation, Autologous
4
2022
463
0.330
Why?
Adoptive Transfer
1
2022
30
0.200
Why?
Cancer Vaccines
1
2022
78
0.190
Why?
CD8-Positive T-Lymphocytes
1
2022
123
0.180
Why?
CD4-Positive T-Lymphocytes
1
2022
157
0.180
Why?
Hepatic Veno-Occlusive Disease
1
2020
9
0.180
Why?
Vaccination
1
2022
275
0.170
Why?
Multiple Myeloma
3
2022
2934
0.170
Why?
Induction Chemotherapy
1
2018
60
0.150
Why?
Transplantation Conditioning
1
2018
82
0.150
Why?
Hepatitis B Antibodies
1
2017
6
0.140
Why?
CDC2-CDC28 Kinases
1
2016
11
0.140
Why?
Virus Activation
1
2017
35
0.140
Why?
Gene Amplification
1
2016
57
0.130
Why?
Incidence
2
2020
1000
0.060
Why?
Survival Analysis
2
2017
670
0.060
Why?
Case-Control Studies
2
2017
1145
0.050
Why?
Disease-Free Survival
1
2022
450
0.050
Why?
Ascites
1
2020
29
0.040
Why?
Aged
3
2018
9505
0.040
Why?
Survival Rate
1
2022
906
0.040
Why?
Male
4
2022
25572
0.040
Why?
Female
4
2022
26829
0.040
Why?
Middle Aged
3
2018
12356
0.040
Why?
Adult
3
2018
13486
0.040
Why?
Treatment Outcome
2
2018
5203
0.030
Why?
Chromosomes, Human, Pair 13
1
2016
38
0.030
Why?
Humans
5
2022
50201
0.030
Why?
Chromosome Aberrations
1
2016
295
0.030
Why?
Retrospective Studies
2
2017
6190
0.030
Why?
Honhar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description